Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin +/- Solifenacin for LUTS/OAB in Men
NCT02715024Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2007
- Primary completion
- Apr 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in lower urinary tract symptoms (LUTS), overactive bladder (OAB), benign prostatic hyperplasia (BPH), sponsored by Astellas Pharma. Started Sep 2007; status: completed.
02
Drugs
solifenacin
03
Conditions
lower urinary tract symptoms (LUTS)overactive bladder (OAB)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02715024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715024.